T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLDT
1601
Chatham Lodging
CLDT
$590M
| $1.95M | ﹤0.01% |
103,352
+11,940
| +13% | +$234K |
|
|
TC
1602
TuanChe
TC
$55.2M
| $1.93M | ﹤0.01% |
527
| – | – |
|
1603
Kennametal
KMT
$2.35B
| $1.92M | ﹤0.01% |
51,939
+209
| +0.4% | +$7.58K |
|
1604
RLJ Lodging Trust
RLJ
$1.66B
| $1.92M | ﹤0.01% |
108,000
+698
| +0.7% | +$12.7K |
|
1605
First Citizens BancShares
FCNCA
$25.6B
| $1.91M | ﹤0.01% |
4,241
+158
| +4% | +$69.1K |
|
|
IMGN
1606
DELISTED
Immunogen Inc
IMGN
| $1.9M | ﹤0.01% |
875,490
-1,565,274
| -64% | -$3.7M |
|
1607
Fiverr
FVRR
$311M
| $1.89M | ﹤0.01% |
+63,594
| New | +$1.95M |
|
|
X
1608
DELISTED
US Steel
X
| $1.89M | ﹤0.01% |
123,294
+7,435
| +6% | +$115K |
|
1609
LiveRamp
RAMP
$2.3B
| $1.89M | ﹤0.01% |
38,874
+6,769
| +21% | +$367K |
|
1610
Watts Water Technologies
WTS
$12.9B
| $1.88M | ﹤0.01% |
20,172
+66
| +0.3% | +$5.63K |
|
1611
Arcosa
ACA
$7.12B
| $1.88M | ﹤0.01% |
49,935
+1,525
| +3% | +$52.2K |
|
|
LTC
1612
LTC Properties
LTC
$2.1B
| $1.87M | ﹤0.01% |
40,959
+197
| +0.5% | +$8.94K |
|
|
UN
1613
DELISTED
Unilever NV New York Registry Shares
UN
| $1.86M | ﹤0.01% |
30,682
| – | – |
|
1614
New York Times
NYT
$10.3B
| $1.86M | ﹤0.01% |
57,096
+49
| +0.1% | +$1.63K |
|
|
TRTN
1615
DELISTED
Triton International Limited
TRTN
| $1.85M | ﹤0.01% |
56,522
+224
| +0.4% | +$7.09K |
|
|
SRC
1616
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $1.85M | ﹤0.01% |
43,319
+17,286
| +66% | +$730K |
|
1617
Sinclair Inc
SBGI
$1B
| $1.83M | ﹤0.01% |
34,225
-4,497
| -12% | -$228K |
|
1618
Medifast
MED
$130M
| $1.83M | ﹤0.01% |
14,237
+31
| +0.2% | +$4.31K |
|
1619
Park Hotels & Resorts
PK
$2.99B
| $1.82M | ﹤0.01% |
65,998
+458
| +0.7% | +$13.7K |
|
1620
Regal Rexnord
RRX
$11.5B
| $1.82M | ﹤0.01% |
22,234
-76
| -0.3% | -$6.12K |
|
1621
Alcoa
AA
$13.1B
| $1.81M | ﹤0.01% |
77,522
+3,831
| +5% | +$95.5K |
|
1622
The GEO Group
GEO
$4.14B
| $1.81M | ﹤0.01% |
86,206
+297
| +0.3% | +$6.27K |
|
|
ROIC
1623
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $1.8M | ﹤0.01% |
104,932
-91,345
| -47% | -$1.58M |
|
|
MNR
1624
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $1.79M | ﹤0.01% |
132,444
+36,081
| +37% | +$496K |
|
1625
Merit Medical Systems
MMSI
$5.45B
| $1.79M | ﹤0.01% |
30,089
+1,739
| +6% | +$99.7K |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.